Prescient Therapeutics Ltd

ASX:PTX ISIN:AU000000PTX3

Prescient Therapeutics Limited is a clinical-stage oncology company. The Company's principal activities include in-licensing of intellectual property; the preparation for and conduct of clinical trials relating to the Company's products; business development associated with the promotion of its technologies and products, and business development associated with developing collaborative, partnership relationships and corporate transactions. 
 
           

Voir en d'autres langues

Nouvelles

###

133,990 COMPANY PROFILE VIEWS

  • This Page Viewed: (7 derniers jours: 19) (Last 30 Days: 58) (Since Published: 10241) 

Company Data

    Fax
  • (03) 9853 5134 
  • Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Biotechnology 
  • Homepage
  • www.virax.com.au/

More News Results

  • 2024/11/14: Results of Annual General Meeting*
  • 2024/11/14: Chair and CEO AGM Presentation*
  • 2024/10/31: September 2024 Quarterly Update and Appendix 4C*
  • 2024/10/14: Notice of Annual General Meeting/Proxy Form*
  • 2024/10/03: Change of Director's Interest Notice*
  • 2024/10/02: Notification of cessation of securities - PTX*
  • 2024/09/12: Prescient CEO to step down in early 2025*
  • 2024/09/05: PTX Presentation*
  • 2024/08/26: Appendix 4G and Corporate Governance Statement*
  • 2024/08/26: Appendix 4E and 2024 Annual Report*
*refer to company website